期刊文献+

The reversal effects of piperine and(R)-(+)-citronellal on multidrug resistant breast cancer cells 被引量:2

胡椒碱和(R)-(+)-香茅醛对多药耐药乳腺癌细胞的耐药逆转作用(英文)
原文传递
导出
摘要 Multidrug resistance (MDR) in tumor cells can reduce the efficacy of chemotherapy. Overexpression of transporters is an important mechanism for MDR. P-glycoprotein (P-gp) is an ATP-binding cassette transporter frequently expressed in multidrug resistant tumor cells, inducing MDR. To reverse P-gp dependent MDR, anticancer drugs can be administered with P-gp inhibitors. Piperine and (R)-(+)-citronellal both are P-gp inhibitors from dietary sources. In the present study, we aimed to evaluate the MDR reversal effects of piperine and (R)-(+)-citronellal in multidrug resistant MCF-7/DOX cells. The results of cytotoxicity studies indicated that piperine and (R)-(+)-citronellal both could abate the resistance of MCF-7/DOX after 72-h incubation. After 72-h incubation, piperine could dose-dependently down-regulate the MDR1 expression at the mRNA level, while (R)-(+)-citronellal had no effect on the MDR1 expression. Therefore, piperine and (R)-(+)-citronellal both could reverse MDR in MCF-7/DOX cells, and the reversal effect ofpiperine was related to dose-dependent down-regulation of the MDR1 expression at the mRNA level. 肿瘤治疗过程中多药耐药(MDR)的发生会降低化疗药物的疗效。转运体的高表达是引起肿瘤MDR的重要机制。P糖蛋白(P-glycoprotein,P-gp)作为ABC(ATP-binding cassette,ABC)转运体家族的一员,经常在耐药肿瘤细胞中高表达,引起MDR。为了克服P-gp引起的MDR,抗肿瘤药物可以与P-gp抑制剂同时给药。胡椒碱和(R)-(+)-香茅醛都是来源于日常饮食的P-gp抑制剂。在本研究中我们评价了胡椒碱和(R)-(+)-香茅醛在多药耐药乳腺癌细胞系MCF-7/DOX细胞中的耐药逆转作用。经过72小时的孵育后,细胞毒性研究结果表明胡椒碱和(R)-(+)-香茅醛均能降低MCF-7/DOX细胞的耐药性。此外,胡椒碱可以浓度依赖性地下调MDR1基因的mRNA水平,而(R)-(+)-香茅醛对MDR1基因的m RNA水平没有影响。因此,胡椒碱和(R)-(+)-香茅醛可以浓度依赖性地逆转MCF-7/DOX细胞的MDR,胡椒碱的耐药逆转作用与下调MDR1基因的mRNA水平相关。
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2016年第5期351-356,共6页 中国药学(英文版)
关键词 MDR1 PIPERINE (R)-(+)-Citronellal MCF-7/DOX P-GLYCOPROTEIN MDR1 胡椒碱 (R)-(+)-香茅醛 MCF-7/DOX P糖蛋白
  • 相关文献

参考文献18

  • 1Gottesman, M.M.; Fojo, T.; Bates, S.E. Nat. Rev. Cancer 2002, 2, 48-58.
  • 2Nobili, S.; Landini, I.; Mazzei, T. Med. Res. Rev. 2012 32, 1220-1262.
  • 3Ozben, T. FEBS Lett. 2006, 580, 2903- 2909.
  • 4Coley, H.M. Cancer Treat. Rev. 2008, 34, 378-390.
  • 5Yu, M.; Ocana, A.; Tannock, I.F. Cancer Metastasis" Rev 2013, 32, 211-227.
  • 6Callaghan, R.; Luk, F.; Bebawy, M. Drug Metab. Dispos 2014, 42, 623-631.
  • 7Zhang, W.; Han, Y.; Lim, S.L. Expert. Opin. Drug Metab Toxicol. 2009, 5, 789-801.
  • 8Bhardwaj, R.K.; Glaeser, H.; Becquemont, L. J. Pharmacol Exp. Ther. 2002, 302, 645-650.
  • 9Yoshida, N.; Takagi, A.; Kitazawa, H. J. Pharm. Sci 2006, 95, 552-560.
  • 10Yoshida, N.; Koizumi, M.; Adachi, I. Food Chem. Toxicol. 2006, 44, 2033-2039.

同被引文献5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部